References

How I treat elderly patients with diffuse large B-cell lymphoma

10.1182/blood-2010-07-259333 · 2010 · External reference

Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary

10.1093/annonc/mdv018 · 2015 · External reference

Re-examining the role of radiation therapy for diffuse large B-cell lymphoma in the modern era

10.1200/jco.2015.64.9418 · 2016 · External reference

Radiation therapy for diffuse large B-cell lymphoma: Indications, outcomes, and controversies

10.1016/j.ijrobp.2015.12.357 · 2016 · External reference

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

10.1056/nejm199807023390104 · 1998 · External reference

CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin's lymphomas: Update of the Southwest Oncology Group (SWOG) randomized trial

2001 · External reference

Continued risk of relapse independent of treatment modality in limited-stage diffuse large B-cell lymphoma: Final and long-term analysis of Southwest Oncology Group study S8736

10.1200/jco.2015.65.4582 · 2016 · External reference

Older patients with early-stage diffuse large B-cell lymphoma: The role of consolidation radiotherapy after chemoimmunotherapy

10.1080/10428194.2016.1205739 · 2017 · External reference

The role of radiotherapy for patients over age 60 with diffuse large B-cell lymphoma in the rituximab era

10.3109/10428194.2015.1120866 · 2016 · External reference

Limited stage diffuse large B-cell lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients

10.3109/10428194.2014.930853 · 2015 · External reference

Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy

10.1200/jco.2009.27.3441 · 2010 · External reference

Impact of rituximab and radiotherapy on outcome of patients with aggressive B-cell lymphoma and skeletal involvement

10.1200/jco.2012.48.0467 · 2013 · External reference

Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma

10.1200/jco.2013.51.4505 · 2014 · External reference

Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma

10.1002/cncr.30173 · 2016 · External reference

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification

10.1200/jco.2013.54.8800 · 2014 · External reference

Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome

10.1093/annonc/mdm563 · 2008 · External reference

Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA

10.1093/annonc/mdt282 · 2013 · External reference

Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy

10.3109/10428194.2016.1153088 · 2016 · External reference

Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with diffuse large B-cell lymphoma: An Australian retrospective analysis

10.1111/imj.12889 · 2015 · External reference

Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma

10.1200/jco.2007.14.1242 · 2008 · External reference

Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma

10.1007/s00277-010-0956-7 · 2010 · External reference

Influence of dose reduction of vincristine in R-CHOP on outcomes of diffuse large B cell lymphoma

10.1007/s00277-015-2514-9 · 2016 · External reference

Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging

10.1016/j.ijrobp.2011.12.067 · 2012 · External reference

The concept and evolution of involved site radiation therapy for lymphoma

10.1007/s10147-015-0863-y · 2015 · External reference

Risk of second malignancy after non-Hodgkin's lymphoma: A British cohort study

10.1200/jco.2005.04.2200 · 2006 · External reference

Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: A GISL cohort study

10.3324/haematol.12918 · 2008 · External reference

The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma

10.1002/cncr.21971 · 2006 · External reference